ZIVO Bioscience and Tianjin Norland Biotech Execute Letter of Intent to Produce ZIVO Algae Strain in China for International and Domestic Markets
01 févr. 2018 07h52 HE | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Feb. 01, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO), a biotech/agtech R&D company engaged in the commercialization of nutritional and medicinal products...
visiongain-logo-72dpi.jpg
Visiongain launches report entitled Alzheimer’s disease therapeutics and diagnostics market 2017-2027
11 janv. 2018 08h31 HE | Visiongain Ltd
LONDON, Jan. 11, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Disease Therapeutics and Diagnostics Market reached $6.71bn in 2016. The Alzheimer’s Disease Therapeutics and Diagnostics Market is expected...
ZIVO Bioscience Subsidiary Wellmetris Selected to Present at Biotech Showcase During JPMorgan Healthcare Conference Jan 7-10 in San Francisco, CA
08 janv. 2018 08h00 HE | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO), a biotech/agtech R&D company, announced today that its WellMetris subsidiary will be presenting at...
Biodesix_lockup_r_rgb (2).jpg
Data Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors
20 déc. 2017 10h00 HE | Biodesix, Inc.
BOULDER, Colo., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Findings published in the American Association for Cancer Research (AACR) peer-reviewed journal Cancer Immunology Research demonstrate that a test...
Biodesix_lockup_r_rgb (2).jpg
Biodesix Announces New Data Demonstrating Analytic Validity of Automated RNA Extraction from Plasma with the GeneStrat® Test
16 nov. 2017 15h40 HE | Biodesix, Inc.
BOULDER, Colo., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Biodesix® announced data demonstrating that a novel, automated method for extracting circulating RNA from plasma performed equivalently or better...
LogoPressRelease.jpg
Fluidigm to Unveil High-Parameter Tissue Imaging System
18 oct. 2017 09h00 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it will unveil a commercially available system for high-parameter tissue...
AMR Logo.png
Global DNA Sequencing Market Expected to Reach $18,284 Million by 2023 - Allied Market Research
30 mai 2017 11h00 HE | Allied Market Research
Portland, United States, May 30, 2017 (GLOBE NEWSWIRE) -- According to a new report published by Allied Market Research, titled, "DNA Sequencing Market : Global Opportunity Analysis and Industry...
DiamiR Announces Oral Presentation at AD/PD(TM) 2017
29 mars 2017 08h02 HE | DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 29, 2017) - DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Samuil...
Telemynd.png
Dr. Mark Schiller to present “The use of PEER to Personalize Medicine” at IPEG
26 oct. 2016 05h00 HE | MYnd Analytics, Inc.
NIJMEGEN, The Netherlands, Oct. 26, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. ("MYnd") (OTCQB:MYAN), Dr. Mark Schiller, Medical Director - MYnd Analytics, will present at the International...
Telemynd.png
MYnd Analytics presents to the American Legion Committee on PTSD/TBI
12 oct. 2016 05h00 HE | MYnd Analytics, Inc.
MISSION VIEJO, Calif., Oct. 12, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (“MYnd”) (OTCQB:MYAN), which provides a unique set of reference data and analytic tools for clinicians to assist in...